July 25, 2025

Rare Pediatric Knee Fractures Reviewed in Depth

Pediatric tibial tubercle fractures continue to present diagnostic and treatment challenges as clinicians navigate variable imaging use, classification systems, and surgical thresholds in the absence of standardized guidelines.

Conexiant

July 22, 2025

Placenta Accreta Guidelines Lack Consensus: Review

A new review of clinical guidelines highlights consistent recommendations for diagnosing and managing placenta accreta spectrum disorders, but showed gaps in guidance for surgery, fertility counseling, and postnatal care, especially in low-resource settings.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

April 24, 2025

Large Trial Finds No Stroke Benefit From CEP, Study

A large U.K. trial found that routine use of cerebral embolic protection did not decrease the incidence of stroke within 72 hours among patients undergoing TAVI.

Conexiant

April 29, 2025

Surgical Management of Foreign Body Ingestion in Adults: Case Series

Diagnosis relies heavily on a careful history, including the nature of the ingested material, and complementary imaging studies.

Conexiant

April 02, 2025

FDA Misses Novavax Decision Date

FDA misses April 1 deadline for deciding on Novavax's COVID-19 vaccine.

Reuters

April 17, 2025

Early Ezetimibe After MI Tied to Reduced MACE in SWEDEHEART Registry

Delaying ezetimibe use after MI was associated with worse outcomes in a Swedish national cohort study of 35,826 patients.

Conexiant

April 03, 2025

Pulmonary Embolism in ESKD: New Data on Risk, Outcomes

Fewer than half of patients with end-stage kidney disease who survived pulmonary embolism filled an anticoagulation prescription, yet PE recurrence rates were similar between those who did and did not receive anticoagulation (4.2% vs. 2.8%; P = .11), according to a new study.

Conexiant

April 02, 2025

FDA Approves Automated Latent TB Test

Revvity’s Auto-Pure 2400 platform for use with the T-SPOT.TB test to automate latent tuberculosis diagnostics was approved by the FDA.

Conexiant